This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
SEE YOU NEXT YEAR: May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Abzu

Profile

Abzu® was born from the desire to challenge the fundamental assumptions of contemporary, black-box AI. Abzu’s pioneering technology, the QLattice®, is a research engine that accelerates exploration, enabling scientists to bring drugs to market faster.

The QLattice introduces a new standard of interpretability and explainability to life science data sets. Through simple models and straightforward mathematical expressions, Abzu’s QLattice achieves a level of transparency and performance in machine learning that is disrupting domains previously dominated by opaque and cumbersome models.

Founded in January 2018, Abzu is a deep tech startup with offices in Copenhagen, Denmark and Barcelona, Spain.

We're bringing you

  • Discovering RNA Therapeutics with Abzu’s Explainable AI- ROOM 103

    7:45am